* The Center for Molecular and Cellular Biology, and the Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland, 4072, Australia
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Phosphatidylinositide (PI) 3-kinase binds to tyrosyl-phosphorylated insulin receptor substrate-1 (IRS-1) in insulin-treated adipocytes, and this step plays a central role in the regulated movement of the glucose transporter, GLUT4, from intracellular vesicles to the cell surface. PDGF, which also activates PI 3-kinase in adipocytes, has no significant effect on GLUT4 trafficking in these cells. We propose that this specificity may be mediated by differential localization of PI 3-kinase in response to insulin versus PDGF activation. Using subcellular fractionation in 3T3-L1 adipocytes, we show that insulin- and PDGF-stimulated PI 3-kinase activities are located in an intracellular high speed pellet (HSP) and in the plasma membrane (PM), respectively. The HSP is also enriched in IRS-1, insulin-stimulated tyrosyl-phosphorylated IRS-1 and intracellular GLUT4-containing vesicles. Using sucrose density gradient sedimentation, we have been able to segregate the HSP into two separate subfractions: one enriched in IRS-1, tyrosyl-phosphorylated IRS-1, PI 3-kinase as well as cytoskeletal elements, and another enriched in membranes, including intracellular GLUT4 vesicles. Treatment of the HSP with nonionic detergent, liberates all membrane constituents, whereas IRS-1 and PI 3-kinase remain insoluble. Conversely, at high ionic strength, membranes remain intact, whereas IRS-1 and PI 3-kinase become freely soluble. We further show that this IRS-1-PI 3-kinase complex exists in CHO cells overexpressing IRS-1 and, in these cells, the cytosolic pool of IRS-1 and PI 3-kinase is released subsequent to permeabilization with Streptolysin-O, whereas the particulate fraction of these proteins is retained. These data suggest that IRS-1, PI 3-kinase, as well as other signaling intermediates, may form preassembled complexes that may be associated with the actin cytoskeleton. This complex must be in close apposition to the cell surface, enabling access to the insulin receptor and presumably other signaling molecules that somehow confer the absolute specificity of insulin signaling in these cells.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CELL proliferation, differentiation, and metabolism
are regulated by an extensive array of hormones,
cytokines, and growth factors. Although the biological endpoints of these regulatory mechanisms are quite
unique, there is tremendous overlap during the intermediate steps comprising the signal transduction machinery. For example, insulin, EGF, PDGF, haematopoietic factors
including B cell receptor antigen and several interleukins,
and clotting factors, such as thrombin, all stimulate the
Ras/mitogen-activated protein kinase (MAPK)1 and the
phosphatidylinositide (PI) 3-kinase-Akt pathways (Kucera and Rittenhouse, 1990; Cambier and Campbell, 1992
;
Gold et al., 1992
; Lev et al., 1992
; Izuhara and Harada,
1993
; Kazlauskas, 1994
). Yet each of these factors initiates
a specific biological response in accord with the physiological requirements of the cell. Thus, a major challenge is to
establish how different hormones and growth factors
achieve their biological specificity, in view of this apparent
redundancy in signaling. One way of achieving specificity
in multicellular organisms is via the cell-specific expression of different receptors. Another, is by a combinatorial mechanism of signaling. This latter mechanism, which is
still probably the most commonly held view, has been supported by the realization that each of the signaling molecules that make up these signaling pathways belong to
large gene families (Marshall, 1994
; Toker and Cantley,
1997
). In unicellular organisms, such as yeast, there are at
least three isoforms of both MAPK and MAPK-kinase, and each isoform is located on distinct downstream pathways that coordinate a particular biological action in response to unique stimuli (Posas and Saito, 1997
).
Another level of specificity may be derived from the intracellular location of different signaling molecules. For
example, several growth factors stimulate the translocation of MAPK from the cytosol to the nucleus, where it is
presumably capable of directly accessing downstream targets involved in transcriptional regulation (Gonzalez et al.,
1993). Other signaling molecules, such as Raf and PI 3-kinase,
also move from the cytosol to membrane compartments in
response to activation (Susa et al., 1992
; Traverse et al.,
1993
). Presumably the intracellular targeting of these proteins facilitates their interaction with the appropriate
downstream substrates and/or signaling molecules. Indeed, the expression of Raf and PI 3-kinase isoforms, containing membrane-targeting motifs, results in the constitutive activation of these proteins and downstream signaling
cascades (Stakoe et al., 1994
; Klippel et al., 1996
). In the
case of PI 3-kinase, indiscriminate membrane targeting results in the activation of multiple signaling pathways, thus
underscoring the absolute need to preserve the correct
compartmentalization of this molecule (Klippel et al., 1996
).
This raises the possibility that the recruitment of signaling
molecules to their precise site of action within the cell may
be a central feature of biological specificity. PI 3-kinase
represents one example where pleiotropism may be
achieved by regulating its site of action, because it has been reported that this enzyme can be recruited to a variety of intracellular locations, such as the plasma membrane (PM; Susa et al., 1992
), the microtubule organization centre (Kapeller et al., 1993
), intracellular vesicles
(Heller-Harrison et al., 1996
), or cytoskeleton (Zhang et al.,
1992
), in response to different growth factors.
The present studies focus on the regulation of glucose
metabolism by insulin. Insulin triggers a number of intracellular metabolic pathways in muscle and adipose tissue,
resulting in increased glycogen and/or lipid storage. The
rate of glucose entry into these cells is an important rate
determining step for each of these processes, and so this
has become the focal point of numerous studies. Insulin
stimulates glucose transport in adipocytes by as much as
30-fold, in a process that involves the regulated exocytic movement of a facilitative glucose transporter (GLUT4)
from intracellular membranes to the cell surface (James et
al., 1989; Slot, 1991). This is an ideal biological step with
which to dissect the specificity of downstream signaling
pathways because it is uniquely regulated by insulin and
other hormones, such as EGF, PDGF, or thrombin are incapable of initiating this response (Robinson et al., 1993
; Vandenberghe et al., 1994
; Wiese et al., 1995
).
One signaling protein that has been implicated in insulin-regulated glucose transport is PI 3-kinase (Kotani et al.,
1995). PI 3-kinase is a member of a lipid kinase family and
consists of two subunits: a p85 regulatory and a p110 catalytic subunit (Hiles et al., 1992
). The p85 subunit contains
two SH2 domains and an SH3 domain that facilitate the
interaction of this enzyme with other proteins. Insulin induces a rapid and marked accumulation of the reaction
products of PI 3-kinase activity, phosphatidylinositol 3,4 bisphosphate, and phosphatidylinositol 3,4,5 trisphosphate, in insulin-sensitive cells (Kelly et al., 1992
). The
time course of insulin-activated PI 3-kinase parallels that
of insulin-stimulated glucose transport (Kelly et al., 1992
).
In addition, potent PI 3-kinase inhibitors, such as the fungal metabolite, wortmannin, and the synthetic compound,
LY294002, inhibit both insulin-stimulated glucose transport and the translocation of GLUT4 to the cell surface (Okada et al., 1994
). Consistent with these studies, dominant negative mutants of the p85 regulatory subunit block
insulin-triggered GLUT4 translocation in adipocytes (Kotani et al., 1995
), whereas constitutively activated PI 3-kinase
isoforms promote GLUT4 translocation in these cells (Katagiri et al., 1996
). Collectively, these studies provide compelling evidence in favor of a role for PI 3-kinase in the
regulation of glucose transport by insulin.
One of the challenges in defining a specific role for PI
3-kinase in the regulation of glucose transport is that other
growth factors, such as PDGF, also stimulate PI 3-kinase
activity in adipocytes, but have no significant effect on glucose transport in these cells (Wiese et al., 1995). The mode
of PI 3-kinase activation is quite different for these two
hormones, however, in that PI 3-kinase binds directly to
the PDGF receptor in response to PDGF (Kazlauskas et al.,
1992
), whereas, in response to insulin, PI 3-kinase associates with one of the major substrates of the insulin receptor, insulin receptor substrate-1 (IRS-1; Sun et al., 1991
). IRS-1 is a 160-kD protein that is phosphorylated on multiple tyrosine residues in response to insulin. Two of these
phosphorylation sites exist within a consensus motif
(YMXM) for the binding of the p85 subunit of PI 3-kinase
(Sun et al., 1992
). IRS-1 also contains a phosphotyrosyl-binding domain that appears to facilitate interaction with
the insulin receptor (Gustafson et al., 1995
). In addition,
IRS-1 contains a pleckstrin homology domain that is also
required for insulin-dependent phosphorylation (Yenush et al., 1996
). IRS-1 is rapidly phosphorylated in intact cells after insulin stimulation (maximal within 20-40 s), and it is believed that a significant proportion of IRS-1 (~50%)
undergoes phosphorylation in response to a maximal insulin challenge (Madoff et al., 1988
). It has been suggested
that phosphorylation of IRS-1 occurs at the cell surface
because efficient phosphorylation of this protein can be
achieved under conditions where internalization of the insulin receptor is inhibited (Heller-Harrison et al., 1995
).
Despite this claim, the intracellular location of IRS-1 is not
known. IRS-1 does not contain a transmembrane domain,
nor is there any evidence for posttranslational modification of the protein that would enable it to associate with
membranes. In CHO cells that have been transfected with
the IRS-1 cDNA, the protein appears largely cytosolic as
determined by immunofluorescence microscopy (Sun et al.,
1992
). Subcellular fractionation studies in adipocytes,
however, suggest that IRS-1 is predominantly membrane associated (Kelly and Ruderman, 1993
). Establishing the
intracellular distribution of IRS-1 and PI 3-kinase in adipocytes may provide clues concerning the basis for the biological specificity of insulin action in these cells.
In the present study, we have used differential centrifugation and sucrose density gradient sedimentation to study
the distribution of signaling proteins in adipocytes. We
show that insulin and PDGF recruit PI 3-kinase to distinct
intracellular locations: with PDGF, the major increase was
observed in the PM, whereas with insulin, PI 3-kinase was
recruited to a high speed pellet fraction (HSP) that also
contained IRS-1 and the intracellular pool of GLUT4. Using flotation and velocity sedimentation analysis, we were
able to further fractionate the HSP fraction into two discrete components, one comprising intracellular membranes enriched in GLUT4 and the -adaptin subunit of
the Golgi clathrin-coat, and another containing large protein complexes and cytoskeletal elements. IRS-1 and PI
3-kinase were enriched in the latter fraction, which was detergent insoluble, but readily dissociated at high ionic
strength. Based on these observations, we propose that
signaling molecules such as IRS-1 and PI 3-kinase may be
specifically targeted to a proteinaceous matrix in adipocytes that may be held in place via interactions with the cytoskeleton. Based on the specificity with which insulin acts
upon these effectors at this location, we suggest that this
matrix must be readily accessible to the PM, and uniquely
affords activation of appropriate downstream targets, such
as GLUT4 translocation.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Reagents
3T3-L1 murine fibroblasts were obtained from the American Type Culture Collection (Rockville, MD). All tissue culture reagents were obtained from GIBCO BRL (Gaithersburg, MD), except for FCS, which was purchased from Trace Biosciences (Clayton, Australia). Insulin was purchased from Calbiochem Corp. (San Diego, CA) and PDGF.B was purchased from Boehringer Mannheim (Mannheim, Germany) and Upstate Biotechnology Inc. (Lake Placid, NY). Acrylamide/bis-acrylamide (29:1) was obtained from Bio-Rad (Hercules, CA), and BSA was purchased from ICN Pharmaceuticals Inc. (Costa Mesa, CA). Unless specified, all other biochemicals were obtained from the Sigma Chemical Co. (St. Louis, MO). Streptolysin-O (SLO) was obtained from S. Bhakdi (University of Mainz, Mainz, Germany). BCA reagent, used in protein assays, was obtained from Pierce (Rockville, IL).
Antibodies
The antibodies used in this study were obtained from the following
sources: anti-phosphotyrosine antibody (4G10) from B. Druker (Oregon
Health Sciences University, Portland, OR); anti-IRS-1 polyclonal antibody from G. Lienhard (Dartmouth University, Dartmouth, UK); anti-Grb2 polyclonal antibodies from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA); anti-mSos polyclonal antibodies from D. Bowtel (Peter MacCallum Cancer Institute, Melbourne, Australia); anti--adaptin polyclonal antibodies from M. Robinson (Cambridge University, Cambridge,
UK); anti-Shc and anti-p85PAN polyclonal antibodies were from Upstate
Biotechnology Inc. The GLUT4 antibody (R820) has been described in
detail previously (James et al., 1989
).
Cell Culture
3T3-L1 fibroblasts were cultured in DME supplemented with 10% newborn calf serum, L-glutamine (2 mM), penicillin (50 U/ml), and streptomycin sulfate (50 mg/ml). Cells were grown to confluence and differentiated
to form adipocytes, as previously described (Piper et al., 1991). Adipocytes were routinely used at 10-20 d postdifferentiation. Before experiments, 3T3-L1 adipocytes were incubated in Krebs-Ringer phosphate solution (2.5 mM Hepes, pH 7.4, 120 mM NaCl, 6 mM KCl, 1.2 mM MgSO4,
10 mM CaCl2, 0.4 mM NaH2PO4, 0.6 mM Na2HPO4), supplemented with
2% BSA for 2 h at 37°C to establish basal conditions.
CHO cells, overexpressing the insulin-receptor (IR) and IRS-1 (CHO/
IR/IRS-1; Sun et al., 1992), were a generous gift from M. White (Harvard
University, Cambridge, MA). CHO/IR/IRS-1 cells were routinely cultured
in DME containing 10% FCS, L-glutamine (2 mM), penicillin (50 U/ml), and
streptomycin sulfate (50 mg/ml) supplemented with geneticin (0.8 mg/ml).
Before experiments, confluent CHO/IR/IRS-1 cells were brought to basal
conditions by incubation in DME, free of additives, for 2 h at 37°C.
Cell Permeabilization
In some experiments, cells cultured in 100 mm culture dishes were permeabilized by treatment of cells with the bacterial endotoxin, SLO. Preliminary experiments established that the concentration of SLO required to facilitate propidium iodide staining of the nucleus in 100% of CHO cells and adipocytes was 0.5 µg/ml and 2.0 µg/ml, respectively. Before permeabilization, cells were brought to basal conditions, as outlined above, and washed once in prechilled intracellular (IC) buffer (20 mM Hepes, pH 7.2, 140 mM potassium glutamate, 5 mM EGTA, 5 mM MgCl, 5 mM NaCl). To facilitate the binding of SLO to the cell surface, cells were incubated with the appropriate concentration of SLO in 2 ml of IC buffer for 5 min at 4°C, and then washed once with cold IC buffer. Permeabilization of cells was initiated by incubating cells in 2 ml of IC buffer containing 1 mg/ml BSA, 1 mM dithiothreitol, and an ATP regeneration system (40 IU creatine phosphokinase, 5 mM creatine phosphate, 1 mM ATP) at 37°C for 15 min. Cells were subsequently washed, and subcellular fractions obtained as outlined below.
Subcellular Fractionation of 3T3-L1 Adipocytes
Whole cell lysates were prepared from 3T3-L1 adipocytes cultured in 35 mm tissue culture dishes. After growth factor treatment, cells were rinsed
twice in ice cold PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 1.5 mM KH2PO4, 8 mM Na2HPO4, pH 7.4). Washed cells were frozen in liquid N2, and stored at 70°C. Immediately before assay, frozen cell monolayers were scraped into 500 µl of ice cold lysis buffer A (20 mM Tris, pH
7.5, 1 mM EDTA, 137 mM NaCl, 10% glycerol, 1% NP-40, 1 mM PMSF)
containing phosphatase inhibitors (2 mM sodium orthovanadate, 10 mM
sodium fluoride, 1 mM tetra-sodium pyrophosphate, and 1 mM ammonium molybdate), and mixed for 15 min at 4°C. Cell lysates were centrifuged at 12,500 g in a microfuge (Beckman Instruments, Inc., Palo Alto,
CA) for 15 min at 4°C, and the resultant supernatant cleared of fat particles by filtration through a 0.45-µm filtration unit (Millipore Corp., Bedford, MA).
Subcellular fractions were prepared from 3T3-L1 adipocytes, cultured
in 100 mm tissue culture plates, as previously described (Piper et al.,
1991), with minor modifications. After growth factor treatment, cells were
rinsed rapidly in ice cold TES (20 mM Tris, pH 7.4, 5 mM EDTA, 250 mM
sucrose), and then harvested in ice cold TES containing protease inhibitors (10 µg/ml aprotinin, 10 µg/ml leupeptin, 250 µM PMSF), and phosphatase inhibitors, as noted above. The suspension was homogenized by
10 passages through a cylinder cell homogenizer (H and Y Enterprise,
Redwood City, CA) and subcellular fractions prepared by sequential differential centrifugation steps. Briefly, the homogenate was subjected to centrifugation at 13,000 g using an SS-34 rotor (Sorvall Instruments Division, Newton, CT) at 4°C for 20 min. The resultant pellet was washed and
resuspended in 1 ml of TES, layered onto a 1.12 M sucrose cushion and
centrifuged at 77,000 g for 1 h using an SW-41 rotor (Beckman Instruments Inc.) to obtain PM. The 13,000 g supernatant was centrifuged at
30,000 g using an SS-34 Rotor (Sorvall Instruments Division) for 30 min to
obtain a pellet designated high density microsomes (HDM). The supernatant was cleared of remaining fat particles by filtering through a 0.45-µm
filter (Millipore Corp.) and centrifuged at 175,000 g using a Ti-80 rotor (Beckman Instruments Inc.) to obtain a supernatant, designated cytosol
(CYT) and high speed pellet (HSP). In previous studies, this pellet has
been referred to as the low density microsomal fraction (Piper et al.,
1991
). However, the studies described herein suggest that a large proportion of the protein in this fraction is not directly associated with microsomal membranes, in which case, HSP is a more appropriate designation.
In some experiments the effects of growth factors on the subcellular
distribution of GLUT4 was assessed using the PM lawn technique (Robinson et al., 1992). Briefly, adipocytes cultured on coverslips were treated
with or without growth factor, and then sonicated to remove the majority
of cell components except for fragments of plasma membrane that remained attached to the coverslip. Coverslips were then incubated in
GLUT4 specific antisera, followed by a second incubation with FITC-conjugated secondary antibody. Immunolabeling was visualized by fluorescence microscopy using an Axioscope fluorescent microscope (Zeiss,
Oberkochen, Germany).
Subcellular Fractionation of CHO Cells
An abbreviated differential centrifugation procedure was used to obtain subcellular fractions from CHO/IR/IRS-1 cells. Untreated or insulin-treated cells were washed twice in prechilled fractionation buffer (HES: 20 mM Hepes, pH 7.4, 1 mM EDTA, 250 mM sucrose), and homogenized in HES, supplemented with protease and phosphatase inhibitors, by 15 passages with a teflon homogenizer. The homogenate was then subjected to centrifugation at 15,000 g at 4°C for 15 min using an SS-34 rotor (Sorvall Instruments Division). The 15,000 g supernatant was centrifuged at 175,000 g at 4°C for 1 h 15 min using a Ti-80 rotor (Beckman Instruments Inc.) to yield a pellet designated HSP, and a supernatant designated CYT. Fractions were subjected to immunoblotting or velocity sedimentation analysis as described below.
Immunoprecipitation and PI 3-Kinase Assay
Whole cell lysates (500 µg), subcellular membrane fractions (25-100 µg of
protein), and CYT (200 µg of protein) prepared from treated cells, were
diluted in lysis buffer to a final volume of 500 µl and subjected to immunoprecipitation by incubation with an anti-phosphotyrosine antibody (4G10)
prelinked to protein A/G beads (Pierce). Immunoprecipitations were performed for 2-4 h, or overnight at 4°C. Immunoprecipitated complexes
were collected by centrifugation at 13,000 g for 10 s and washed sequentially in 1% NP-40 in PBS, pH 7.4, and 50 mM LiCl in 100 mM Tris, pH 7.5, and then washed twice in 100 mM NaCl in 10 mM Tris, pH 7.5. In
some experiments, an aliquot of immunocomplexes was removed during
the last wash and retained for Western blotting analysis. The remaining
immunocomplexes were assayed for PI 3-kinase activity as previously outlined (Hara et al., 1994), using phosphatidylinositol as substrate. The reaction products were spotted onto silica-60-coated plates (Merck, Darmstadt, Germany) and subjected to TLC. The radio-labeled phospholipid
product was visualized by autoradiography and then excised from silica
plates and quantitated by scintillation counting (Packard 1900CA; Packard Instrument Co. Inc., Downers Grove, IL). Radio-labeled phosphatidylinositol 3-phosphate (PIP) was identified on the basis of its disappearance in wortmannin-treated cells (data not shown).
Immunoblotting
Proteins were subjected to SDS-PAGE and transferred to Immobilon-P PVDF membranes (Millipore Corp.). Membranes were incubated with either 5% skim milk powder or 3% BSA in TBST (20 mM Tris, pH 7.6, 150 mM NaCl, 0.05% Tween-20), and subsequently incubated with primary antibody, washed and incubated with the appropriate horseradish-peroxidase-linked secondary antibodies (Amersham Intl., Little Chalfont, UK) for 1 h at room temperature. To visualize immunoreactive proteins, membranes were incubated with enhanced chemiluminescence substrate, (Amersham Intl.) or Supersignal (Pierce), and subjected to autoradiography by exposing each membrane to film (X-OMAT; Fuji, Tokyo, Japan).
Treatment of 3T3-L1 Adipocyte HSP Fractions with Detergent or Ionic Buffer
The HSP fraction was prepared from nontreated and insulin-treated 3T3-L1
adipocytes, in fractionation buffer (20 mM Hepes, pH 7.4, 1 mM EDTA,
250 mM sucrose; HES), containing protease and phosphatase inhibitors as
detailed above, and divided into five aliquots of equal volume. Aliquots
were incubated for 1 h on ice, with one of each of the five following solutions to give the final detergent or NaCl concentrations as indicated: HES
alone, pH 7.4; 1% Triton X-100 (Tx-100) in HES, pH 7.4; 60 mM -octylglucoside in HES, pH 7.4; 1 M NaCl in HES, pH 7.4; and 0.5 M NaCl in HES, pH 7.4. The insoluble component of the HSP, resulting from each treatment, was pelleted by centrifugation at 175,000 g, using a TLA 100.3 rotor
(Beckman Instruments Inc.) at 4°C for 1 h 15 min. The resultant pellets
were solubilized with Laemmli sample buffer and stored at
20°C overnight before Western blotting analysis.
Detergent-treated HSP was also prepared for electron microscopy analysis, using a slightly modified procedure. The 30,000 g supernatant was obtained from untreated or insulin-stimulated adipocytes using the subcellular fractionation method, as described above. Aliquots of supernatant were mixed with an equal volume of fractionation buffer or fractionation buffer containing 2% Tx-100 and incubated for 1 h on ice. The insoluble components were collected by centrifugation, as noted above. Immunoblotting showed that the relevant proteins were present in the detergent insoluble components of the HSP, regardless of the method used (data not shown).
Sucrose Gradient Fractionation
In both flotation and velocity sedimentation analysis, gradients or sucrose layers were prepared using chilled stock sucrose solutions in buffer (20 mM Hepes, pH 7.4, 1 mM EDTA) containing phosphatase and protease inhibitors, as above. All sucrose concentrations are expressed as a percentage (wt/vol). For flotation analysis, HSP prepared from untreated or insulin-treated cells, was resuspended in 200 µl of HES. An aliquot of resuspended membranes (165 µl) was mixed with 835 µl of 70% sucrose solution to give a final concentration of 60% sucrose. This was then successively overlaid with 1 ml of 50% sucrose, 1 ml of 30% sucrose, 1 ml of 10% sucrose, and 400 µl of 5% sucrose to give a final volume of 4.4 ml. Gradients were centrifuged (90,000 g for 18 h) at 4°C using an SW60 rotor (Beckman Instruments Inc.). Gradient fractions (400 µl) were collected by piercing the bottom of each tube with a 27-in gauge needle. The pellet was resuspended in either 400 µl of HES or lysis buffer, as appropriate. Aliquots of each fraction were then subjected to immunoblotting (25 µl) or immunoprecipitation and PI 3-kinase assay (100 µl).
Velocity sedimentation analysis of the HSP fraction was performed in continuous (5-30%) sucrose gradients (4.2 ml). The HSP fraction was prepared from untreated or insulin-treated cells, and resuspended in 5% sucrose in 20 mM Hepes, 1 mM EDTA, and layered on top of the gradient. Gradients were centrifuged (90,000 g for 90 min) at 4°C using an SW60 rotor (Beckman Instruments Inc.). Fractions from each gradient were collected as noted above, and aliquots (25 µl) subjected to immunoblotting. For electron microscopy, fractions of interest were combined and diluted in buffer, supplemented with protease and phosphatase inhibitors, to give a final concentration of 250 mM (isotonic) sucrose. Each sample was then subjected to centrifugation at 175,000 g using a TLA 100.3 rotor (Beckman Instruments Inc.) at 4°C for 1 h 15 min. Pellets obtained from this centrifugation were prepared for electron microscopy.
Electron Microscopy
The HSP fraction, the detergent insoluble components of the HSP, or sedimentable material from velocity gradient fractions of the HSP, were fixed in 2% paraformaldehyde in PBS. Paraformaldehyde-fixed material was randomly adsorbed to formvar-coated copper grids lightly coated with carbon. Dry grids were incubated on 10 µl drops of HSP suspensions for 10 min. All grids were then washed for 7 × 2 min with ultra-pure water and stained with 0.4% uranylacetate in 0.015 M oxalic acid, pH 7-8/1.8%, methylcellulose for 5 min. Grids were dried and viewed using a Jeol 1010 transmission electron microscope.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Effects of Insulin versus PDGF on Glucose Transport and PI 3-Kinase in 3T3-L1 Adipocytes
In agreement with previous studies (Wiese et al., 1995), insulin stimulated glucose transport by 8- to 10-fold in 3T3-L1
adipocytes, whereas in response to PDGF, the increase
was <2-fold (data not shown). To determine if this was
due to a differential effect of these growth factors on
GLUT4 translocation, adipocytes were incubated with insulin or PDGF or without any additions, and cell surface
levels of GLUT4 examined. Consistent with the transport data, insulin caused a substantial increase in cell surface
GLUT4, whereas, with PDGF, there was no significant effect (Fig. 1). In contrast, PI 3-kinase activity measured in
anti-phosphotyrosine (anti-pY) immunocomplexes was increased by 8- and 10-fold of insulin and PDGF, respectively (Fig. 2). The increases in PI 3-kinase activity correlated with an increase in the binding of the p85 subunit of
PI 3-kinase to tyrosyl-phosphorylated proteins, in response to insulin or PDGF (Fig. 2). These data are in
agreement with previous observations (Wiese et al., 1995
).
|
|
Differential Localization of PI 3-kinase in Response to Insulin versus PDGF
To study the effects of insulin versus PDGF on the intracellular location of PI 3-kinase, a series of subcellular fractionation studies, using 3T3-L1 adipocytes, was performed.
Adipocytes provide a useful model system for these studies, because a relatively simple fractionation procedure
has been established using differential centrifugation that
enables the isolation of fractions enriched in markers specific for PM; mitochondria/nuclei (M/N); endosomes and
endoplasmic reticulum (HDM); and intracellular membranes comprising recycling endosomes, the Golgi apparatus, and intracellular GLUT4 storage vesicles (HSP; Simpson et al., 1983; James and Pilch, 1988
; Piper et al., 1991
;
Martin et al., 1996
). The supernatant contains all elements
that do not sediment at 175,000 g and is designated the
CYT. In most studies, the M/N fraction was excluded from
analysis because preliminary experiments showed that the relevant signaling molecules were not present in this fraction at significant levels.
PI 3-kinase activity was measured in anti-pY immunocomplexes obtained from subcellular fractions of cells that had been incubated with either insulin or PDGF (Fig. 3 A). In the basal state, phosphotyrosine immunoprecipitable PI 3-kinase activity was predominantly located in the cytosol. In response to insulin, the largest increase in PI 3-kinase activity was detected in the HSP (9-11-fold compared to basal, n = 3), and this fraction contained the largest proportion of total cellular PI 3-kinase activity (53%; Fig. 3 C). Insulin also caused a small but significant increase in PI 3-kinase activity in CYT, HDM, and PM fractions. In response to PDGF, the distribution of PI 3-kinase was significantly different to that observed with insulin. The predominant PDGF-stimulated PI 3-kinase activity was found in the PM (>40-fold compared to basal, n = 3) This fraction also contained the majority (56%), of the total cellular PI 3-kinase activity detected in response to PDGF. PDGF also induced a significant increase in the HDM but had no significant effect on PI 3-kinase activity in either cytosol or HSP. These changes in general, paralleled the distribution of anti-phosphotyrosine immunoprecipitable p85 (Fig. 3 B).
|
Given that the above measurements were performed on
anti-pY immunoprecipitates, we could not be certain that
these measurements truly reflected the distribution of PI
3-kinase within adipocytes. To address this, the distribution of the p85 subunit of PI 3-kinase was analyzed by
immunoblotting with an antibody raised against p85 (anti-p85 PAN). The predominant band that was consistently labeled with this antibody in adipocytes had an average mobility in SDS-PAGE of 85 kD (Fig. 4 A). However, other
bands of average mobility corresponding to ~100, 45, and
55 kD were routinely observed. The latter two bands likely
correspond to previously reported isoforms or splice variants of this enzyme that have been shown to cross-react
with the p85 antibody used in these studies (Inukai et al.,
1997). In the absence of hormone, the majority of immunoreactive p85 was found in the cytosol and HSP. With insulin there was a two- to threefold increase in the immunoreactive p85 in the HSP fraction, commensurate with a
decrease in the cytosol and relatively little change in the
PM. In response to PDGF, there was a fivefold increase in
immunoreactive p85 in the PM, and no change in either
the HSP fraction or cytosol. The differential distribution
of immunoreactive p85 in different fractions of cells
treated with insulin versus PDGF is similar to that observed in anti-pY immunocomplexes (Fig. 3 B). We did
not observe any significant change in the distribution of either the p45 or p55 immunoreactive species, suggesting
that these proteins do not respond to these growth factors.
The p55 band was enriched in the PM, whereas p45 was
enriched in the cytosol (Fig. 4 A).
|
The profile and subcellular distribution of tyrosine
phosphorylated proteins observed in response to insulin,
was distinctly different from that observed in response to
PDGF (Fig. 4 B). Tyrosyl-phosphorylated IRS-1 (180 kD)
was enriched in the HSP, in agreement with previous studies (Kelly and Ruderman, 1993; Heller-Harrison et al.,
1995
). Several other insulin-regulated tyrosyl phosphoproteins in the molecular mass range 50-150 kD were also detected in the HSP. The 95-kD species presumably corresponds to the IR
-subunit. In agreement with previous
studies, this protein is highly enriched in the PM (Kublaoui et al., 1995
). The identity of the other insulin-regulated phosphotyrosine proteins in the HSP is not known.
Insulin also stimulated tyrosine phosphorylation of proteins of molecular mass 60 and 53 kD in the PM, that may
correspond to p60 (IRS-3; Lavan et al., 1997
) and another
recently identified insulin receptor-tyrosine kinase substrate, p53/p58 (Yeh et al., 1996
), respectively. None of
these insulin-stimulated phosphotyrosine proteins were
observed in PDGF-treated cells (Fig. 4 B). The major
phosphotyrosine protein (195 kD) observed in PDGF-treated cells was enriched in the PM and HDM and has an
identical electrophoretic mobility to the immunoreactive murine PDGF receptor (data not shown).
Subcellular Distribution of IRS-1, Grb2, mSos, and Shc
As described above, PI 3-kinase and tyrosyl-phosphorylated IRS-1 are enriched in the HSP fraction isolated from
adipocytes, in agreement with previous studies (Kelly and
Ruderman, 1993; Heller-Harrison et al., 1995
; Kublaoui et al.,
1995
). As shown in Fig. 5, immunoreactive IRS-1 is also
enriched in this fraction. It is noteworthy that the IRS-1
antibody labels two proteins in the HSP of average mobility 165 and 120 kD. The upper of these two bands has a
relative molecular mass which corresponds to IRS-1 and
undergoes an apparent shift in molecular mass from 165 to 180 kD in response to insulin. It has previously been documented that IRS-1 undergoes a gel shift subsequent to
phosphorylation (Sun et al., 1992
). The lower band likely
represents an unrelated protein that cross-reacts with the
antibody, as opposed to IRS-1 degradation, because we
failed to observe any evidence for tyrosine phosphorylation of a protein in this region of the gel (Fig. 4 B). In some
experiments, insulin resulted in a redistribution of IRS-1
from the HSP fraction to cytosol, consistent with previous studies (Heller-Harrison et al., 1995
). Presumably, the insulin-induced redistribution of IRS-1 to the cytosol accounts
for the phosphotyrosine immunoprecipitable PI 3-kinase
activity detected in the cytosolic fraction from insulin-treated cells, as shown above (Fig. 3, A and C). We did not
observe any significant change in the subcellular distribution of IRS-1 in response to PDGF treatment (data not shown).
|
Insulin is known to activate numerous signaling molecules in adipocytes. These include, Grb2, another SH2 domain containing protein, that reportedly binds to IRS-1 in
response to insulin (Sun et al., 1993) ; mSOS, a Grb2-binding protein (Baltensperger et al., 1993
) that acts as a GTP
exchange factor for p21 Ras; and Shc, another insulin-regulated docking protein (Skolnik et al., 1993
). We next examined the distribution of these proteins in adipocytes to
determine if the localization of IRS-1 and PI 3-kinase to
the HSP fraction is specific or, alternatively, reflects a general depot for signaling proteins (Fig. 5). In support of the
former, none of these proteins, with the exception of one of the Shc isoforms, was enriched in the HSP fraction.
Grb2 was found in all subcellular fractions in 3T3-L1 adipocytes, but was particularly enriched in the PM. In response to insulin, there was a significant increase in the
level of Grb2 in the PM and HSP fractions, perhaps due to
its interaction with tyrosine-phosphorylated p60 (IRS-3)
and IRS-1, which are enriched in each of these fractions, respectively (Fig. 4 B). mSOS was highly enriched in the
cytosol and did not undergo a change in subcellular distribution in response to insulin stimulation. Hence, unless
mSos dissociated from Grb2 during the isolation of these
fractions, it would appear that Grb2 must bind to additional proteins in adipocytes other than mSOS, and thus
potentially recruits unique signaling proteins to either the
PM or HSP fractions.
The subcellular distribution of Shc was of particular interest because this molecule encodes a similar function to
IRS-1, acting as a docking protein for downstream signaling proteins (Skolnik et al., 1993). Furthermore, three different Shc isoforms have been reported, the individual
functions of which remain to be elucidated (Pelicci et al.,
1992
). All three isoforms were detected in 3T3-L1 adipocytes (Fig. 5) and, intriguingly, the subcellular distribution
of each was completely different. The 66-kD isoform was
enriched in the HDM with lower amounts also found in
the PM. The 46-kD isoform was highly enriched in the PM
(Fig. 5) and M/N (data not shown) while the 52-kD isoform was more widely distributed, with the majority located in the cytosol and the HSP. Insulin did not significantly affect the subcellular distribution of any Shc
isoform. These data clearly show that signaling proteins
have widely varying subcellular distributions in adipocytes
and this may have important implications for the specificity of their biological actions. Moreover, the distribution of Grb2, mSos, and Shc did not parallel that of IRS-1. This
implies that IRS-1 must be maintained at this location by a
specific association with another protein or membrane.
Effects of Detergents and High Ionic Strength on IRS-1 and PI 3-kinase Solubility
To further define the nature of the interaction of IRS-1
and PI 3-kinase with the HSP, we examined the effects of
high ionic strength and different detergents on the solubility of these proteins (Fig. 6). Immunoreactive IRS-1, tyrosyl-phosphorylated IRS-1, and PI 3-kinase remained
largely insoluble in the presence of the two nonionic detergents, Tx-100 and -octylglucoside (
-OG). Under exactly
the same conditions, the polytopic membrane protein, GLUT4, was completely solubilized. In contrast, denaturing detergents such as SDS, completely solubilized both
IRS-1 and PI 3-kinase (data not shown). It has been suggested that specialized vesicular compartments including
clathrin-coated vesicles and caveolae remain insoluble in
certain detergents (Pearse, 1982
; Kurchalia et al., 1992
). In
this regard, it was of interest that the
-adaptin subunit of
clathrin-coated vesicles was also largely insoluble in Tx-100 and
-OG (Fig. 6). However, as shown in Fig. 7, a large
proportion of the
-adaptin in this fraction is not associated with membranes and so this presumably represents
preassembled adaptor complexes that can be sedimented.
It is highly unlikely that the detergent insoluble fraction,
containing IRS-1 and PI 3-kinase, represents caveolae because these organelles are generally quite soluble in the
nonionic detergent
-OG (Brown and Rose, 1992
). Moreover, we have shown that caveolin, a major constituent of
caveolae, is not enriched in our HSP fraction, but remains
attached to the plasma membrane. In addition, the minor
pool of caveolin found in the HSP, is substantially solubilized by 1% Tx-100 (Hill, M., S. Clark, D. James, manuscript submitted for publication). In the presence of high
ionic strength, both IRS-1 and PI 3-kinase were completely solubilized, suggesting that these proteins are retained in the HSP fraction via ionic interactions (Fig. 6).
|
|
PI 3-kinase-IRS-1 Complexes Are Not Associated with Membranes within the Adipocyte HSP
Specialized lipid micro-domains have been described,
based on their resistance to solubilization with various
nonionic detergents (Simons and Ikonen, 1997). These domains may be enriched in certain membrane lipids, such as
glycolipids that confer detergent insolubility. One of the
features that defines these types of structures, aside from
detergent insolubility, is their buoyancy in hypertonic sucrose, due to the presence of lipid (Brown and Rose,
1992
). In contrast, protein complexes and cytoskeletal elements do not exhibit this property (Fra et al., 1994
). To determine if IRS-1 and PI 3-kinase are localized to a specialized lipid microdomain, the HSP fraction was loaded at
the bottom of a discontinuous sucrose gradient and centrifuged for 18 h (Fig. 7). The HSP was resolved into two separate peaks of protein using this approach. The major
peak (peak 1), which contained ~65% of HSP protein, remained at the bottom of the gradient in the 60% sucrose
fraction. The second peak (peak 2) contained ~33% of
HSP protein and was found in the middle of the gradient
corresponding to the 30/50% sucrose interface. The distribution and recovery of protein in peaks 1 and 2 were not significantly different when HSP fractions were harvested
from basal versus insulin-treated cells (Fig. 7, A and B).
IRS-1 and PI 3 kinase were found exclusively in peak 1 both in basal and insulin-treated cells. Notably, we observed in these studies an insulin-dependent loss of IRS-1
from the HSP fraction that was presumably due to the redistribution of this protein to the cytosol (Figs. 5 and 6).
Consistent with the studies described above (Fig. 4), there
was a significant increase in IRS-1 tyrosine phosphorylation with insulin and an increase in PI 3-kinase associated with
the HSP. However, these effects of insulin were only observed in peak 1, suggesting that neither IRS-1 nor PI 3-kinase
are associated with lipid-containing domains. As a control
for the flotation analysis we also immunoblotted each fraction with an antibody specific for GLUT4. As expected,
GLUT4-containing membranes quantitatively floated to a
position in the gradient, corresponding to peak 2, proportional to the buoyant density of these membranes. In addition, it was noted that the amount of GLUT4 recovered in
peak 2 from insulin-treated cells was significantly less than
that from basal cells consistent with its movement from
the HSP to the plasma membrane (see Fig. 1). This indicates that peak 2 contains the insulin-regulatable GLUT4
storage vesicles. Fractions were also immunoblotted with
an antibody specific for
-adaptin. Although the majority
of this protein remained in peak 1, presumably representing preformed adaptor complexes, a significant amount
was also found in peak 2. Hence, this indicates that the
HSP contains coated vesicles and these remain intact during this fractionation procedure. A tyrosine-phosphorylated protein of Mr 95 kD, presumably corresponding to
the
subunit of the IR, was also detected in peak 2 isolated from insulin-treated cells (Fig. 7 B).
These studies suggest that we have been able to segregate the HSP into two distinct fractions corresponding to
peaks 1 and 2. Peak 1 contains the majority of protein as
well as IRS-1 and PI 3-kinase, whereas peak 2 contains
membranes and vesicles as determined by the presence of
GLUT4, the IR and -adaptin. To rule out the possibility
that a small amount of IRS-1 or PI 3-kinase, that is undetectable by immunoblotting, may remain associated with
membranes in peak 2, we also measured PI 3-kinase activity in phosphotyrosine immunoprecipitates of each fraction from flotation gradients. This assay is much more sensitive than blotting and should provide a more quantitative
measure of the distribution of this protein. Consistent with
the distribution of immunoreactive p85 (Fig. 7 B), the majority (95%) of insulin-stimulated PI 3-kinase activity was
recovered in peak 1 and the activity present in peak 2 was
not significantly different from background (Fig. 7 C). Hence, these data indicate that PI 3-kinase does not associate with membranes within the HSP.
One possibility is that IRS-1 and PI 3-kinase complexes may dissociate from membranes during the flotation analysis and, thus, remain at the bottom of the gradient as free protein. If this were the case, it would be expected that these proteins would now behave as cytosolic proteins, and not sediment under the conditions that were originally used to generate this fraction. To address this possibility, the 60% sucrose fractions (F1 and F2) that comprised peak 1 from flotation gradients were diluted with buffer to achieve an isotonic sucrose concentration and resedimented. As shown in Fig. 8, a large proportion of both IRS-1 and PI 3-kinase were recovered in the pellets (P1 and P2) from both of these fractions. Thus, these data suggest that IRS-1 and PI 3-kinase are not associated with membranes in the HSP fraction and that their presence in this fraction must reflect an interaction with other proteins that render them detergent insoluble.
|
Velocity Sedimentation Analysis of the HSP
To further characterize the nature of the IRS-1-PI 3-kinase complex in adipocytes, we next subjected the HSP to velocity sedimentation analysis. This procedure separates particles on the basis of size rather than density. Under these conditions the majority of protein (68%) in the HSP remained at the top of the gradient (fractions 8-10) and, consistent with the flotation analysis, this peak contained the majority of IRS-1, tyrosyl-phosphorylated IRS-1 and PI 3-kinase (Fig. 9, A and B). Insulin stimulation did not substantially alter the velocity sedimentation profile of total protein nor IRS-1 (Fig. 9 B). However, we again observed an insulin-dependent loss of IRS-1 from the HSP which was presumably due to the re-distribution of this protein to the cytosol (Fig. 7, A and B). The insulin-stimulated increase in PI 3-kinase in the HSP cosedimented with the pool of tyrosyl-phosphorylated IRS-1. The majority (>80%) of immunoreactive GLUT4 in the HSP sedimented in zones (fractions 2-7) of the gradient that were devoid of IRS-1 and PI 3-kinase. There was a slight overlap between the GLUT4 peak and the IRS-1-PI 3-kinase peak. However, in view of the flotation studies described above, this almost certainly corresponds to the limited resolution of this technique and does not reflect colocalization of these proteins. Hence, using this technique, it would appear that IRS-1 and PI 3-kinase that remain in the upper portion of the velocity gradient, are not associated with membranes that sediment deeper into the gradient.
|
IRS-1 and PI 3-Kinase Have Similar Properties in Other Cell Types
IRS-1 is expressed at high levels in insulin-sensitive cell
types, including adipocytes and myocytes (White, 1994).
To determine if the association of IRS-1 and PI 3-kinase
with insoluble proteinaceous particles is only a feature of
these cell types, we performed similar experiments, to
those described above, in CHO cells. CHO cells do not
normally express significant levels of either IR or IRS-1
and this, in part, accounts for their lack of insulin sensitivity. Hence, we used CHO cells that have been stably transfected with the IR and IRS-1 cDNAs (Sun et al., 1992
).
Consistent with previous studies (Heller-Harrison et al.,
1995
), we observed that a significant fraction of both IRS-1
and PI 3-kinase in these cells was found in an HSP fraction
(see Fig. 11). The CHO/IR/IRS-1 cell HSP was next subjected to velocity gradient analysis and fractions were immunoblotted as described above (Fig. 10, A and B). The
distribution of IRS-1, tyrosyl-phosphorylated IRS-1, and p85 in CHO cells was almost identical to that observed in
adipocytes (Fig. 9). Moreover, insulin induced a significant
increase in IRS-1 tyrosine phosphorylation and recruitment of PI 3-kinase in CHO/IR/IRS-1 cells that was commensurate with that observed in adipocytes (Fig. 10, B).
Hence, these data suggest that the nonmembrane associated, insolubility of IRS-1 and PI 3-kinase that presumably
results from the association of these proteins with a large
protein complex, is a feature of many cells, and can be recapitulated using recombinant IRS-1 expressed in a cell type that normally expresses low levels of this protein.
|
|
Maintenance of the IRS-1-PI 3-Kinase Complex in Permeabilized Cells
The cytosolic or nonsedimentable pool of both IRS-1 and PI 3-kinase in CHO/IR/IRS-1 cells is significantly larger than is observed in adipocytes and can be readily detected by immunoblotting. Hence, this provided a useful system with which to experimentally define the existence of the two pools, cytosolic versus insoluble, of IRS-1 and PI 3-kinase in the intact cell. If the insoluble sedimentable pool of IRS-1 and PI 3-kinase represents a large preformed protein complex within the cell, then it should be retained after permeabilization. Whereas, provided the pores are sufficiently large, the cytosolic component of these proteins should be released from the cell under the same experimental conditions. The bacterial endotoxin, SLO, provides a useful reagent to achieve this purpose because it introduces large pores in the plasma membrane, leaving the remainder of the cell completely intact. As shown in Fig. 11, the majority of IRS-1 and immunoreactive p85 found in the cytosolic fraction was released from cells subsequent to permeabilization with SLO. In contrast, a substantial proportion of immunoreactive p85 and IRS-1, associated with the HSP fraction, was retained in permeabilized cells. We have also shown that a significant proportion of IRS-1 and PI 3-kinase is retained in SLO-permeabilized 3T3-L1 adipocytes (data not shown). However, because we do not observe a significant amount of IRS-1 in the cytosol of these cells, we have not been able to examine the release of this pool subsequent to permeabilization and, as is shown in the case of the CHO/IR/IRS-1 cells, this provides a very useful control. Notwithstanding, these studies collectively demonstrate that the insoluble fraction of IRS-1 and PI 3-kinase, which we have isolated biochemically in these studies, can also be experimentally defined as a large complex that is retained in cells, even under conditions where the cytosolic component of these same proteins is freely permeable.
Electron Microscopy Analysis of the HSP
We have previously shown that the HSP fraction isolated
from adipocytes contains numerous vesicles ranging in diameter from 70-200 nm (James and Pilch, 1988; Martin et al.,
1996
). Immunogold labeling studies have revealed that
these vesicles are enriched in a variety of membrane and
coat-associated proteins including GLUT4, VAMP2, and
the mannose-6-phosphate receptor, (Martin et al., 1996
).
As shown in Fig. 12, electron microscopy of the IRS-1-PI 3-kinase peak and the GLUT4 peak, obtained by velocity
centrifugation of the 3T3-L1 adipocyte HSP (Fig. 9), revealed that the latter, but not the former, was highly enriched in vesicles (Fig. 12, A and B). Intriguingly, long, filamentous structures with an estimated diameter of 5-15
nm, that resemble cytoskeletal elements (Kries and Vale,
1993), were preferentially retained in the gradient peak
enriched in IRS-1 and PI 3-kinase. These structures were decorated with electron opaque particles with an estimated diameter of 10-50 nm, that, presumably, correspond to large protein complexes (Fig. 12 A). Similar filamentous structures were present in the Tx-100-insoluble
component of the HSP, although in this instance, they appeared to be less labyrinthine and were decorated with large electron dense sacs (Fig. 12 C). These filamentous
structures are present in the HSP, isolated from a variety
of cell types, including both rat adipocytes and 3T3-L1 adipocytes, but appear more elongated in the HSP isolated
from rat adipocytes (data not shown). Immunolocalization
of either IRS-1 or PI 3-kinase in these fractions have been
unsuccessful and so it remains to be determined if these
proteins are directly associated with these cytoskeletal elements.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
PI 3-kinase plays a central role in numerous biological
processes, including thrombin activation of platelets, apoptosis, growth factor-induced cell proliferation, differentiation, membrane ruffling, and insulin regulation of glucose
metabolism (Toker and Cantley, 1997). Understanding
how this enzyme acts as the focal point for such a diverse
range of biological actions remains a major challenge. In
the present study, we have addressed this problem by focusing on the insulin regulation of glucose transport in adipocytes. This provides a useful paradigm because considerable evidence supports a role for PI 3-kinase in insulin
action and the regulation of glucose transport in adipocytes is quite specific to the hormone, insulin (Robinson
et al., 1993
; Vandenberghe et al., 1994
; Wiese et al., 1995
).
An anomalous observation, that potentially confounded
the specific role of PI 3-kinase in this process, was that
PDGF also activates PI 3-kinase in adipocytes, quantitatively to the same extent as insulin, yet this growth factor is
incapable of activating glucose transport or GLUT4 translocation to the cell surface (Wiese et al., 1995
).
A major difference between insulin and PDGF signaling
is that insulin uses a putatively soluble substrate, IRS-1, as
a docking site for downstream signaling intermediates,
such as PI 3-kinase, whereas PDGF uses its receptor for
this purpose (Kazlauskas et al., 1992). Hence, we reasoned
that this difference may confer specificity at the level of intracellular compartmentation, thus enabling PI 3-kinase to
access a unique array of downstream effectors in either
case. Using subcellular fractionation analysis, we verified this
notion and showed that, in response to PDGF, PI 3-kinase was recruited to the plasma membrane, whereas, in the
case of insulin, PI 3-kinase was recruited to an intracellular
fraction, designated as HSP, that was quite distinct from
the plasma membrane. The PDGF-activated receptor is,
of course, enriched in the plasma membrane fraction,
whereas IRS-1 is enriched in the HSP, consistent with the
original hypothesis. These observations, which represented the impetus for these studies, has since been reported by
two other groups and largely confirms the central tenet
that the cellular location of PI 3-kinase may somehow confer
biological specificity (Nave et al., 1996
; Ricort et al., 1996
).
To further define the molecular basis for this differential compartmentalization of PI 3-kinase, we focused our efforts on characterizing the composition of the adipocyte HSP and, in particular, in defining the nature of the interaction of both IRS-1 and PI 3-kinase with this fraction. Importantly, IRS-1 was enriched in the HSP under basal conditions. Given that the bulk of tyrosyl-phosphorylated IRS-1 in cells treated with insulin remained associated with the HSP, it is more than likely that IRS-1 interacts with the insulin receptor in this fraction (Figs. 4 B and 5). Intriguingly, although insulin recruits PI 3-kinase from the cytosol to the HSP, presumably due to increased binding to tyrosyl-phosphorylated IRS-1, there is a significant component of PI 3-kinase found in the HSP in basal cells (Fig. 4 A). This may reflect PI 3-kinase bound to tyrosyl-phosphorylated IRS-1 because we could detect a phosphotyrosine protein of similar relative molecular mass in the HSP from basal cells (Figs. 4 B and 5). Apart from this, however, there is no a priori reason to suggest that PI 3-kinase is only located at this site by coupling with IRS-1. Indeed, the preassembly of these proteins in a complex may facilitate the necessary fidelity required to ensure that these proteins can rapidly associate in response to insulin. The HSP also contains other signaling molecules such as the 52-kD isoform of Shc, (Fig. 5) as well as other insulin-regulated phosphoproteins of unknown identity (Fig. 4 B; Hill, M., S. Clark, and D. James, manuscript submitted for publication). However, Grb2, the 46 and 66 kD isoforms of Shc (Fig. 5), MAPK (Hill, M., and D. James, unpublished observations), the tyrosyl-phosphorylated insulin receptor and two other insulin-regulated tyrosyl phosphoproteins of relative molecular mass p60 and p53 (Fig. 4 B) are not enriched in this fraction, suggesting that this is not simply an aggrophore of signaling intermediates.
In addition to IRS-1 and PI 3-kinase, the HSP is also enriched in the intracellular GLUT4 storage compartment
(Fig. 7; James et al., 1988). Hence, this raises the provocative notion that PI 3-kinase may directly bind to these vesicles, thus, regulating their exocytic movement. Indeed,
evidence has been documented in favor of this model
(Heller-Harrison et al., 1996
). However, intuitively, this
seems unlikely because PI 3-kinase also mediates the activation of the pp70 ribosomal protein S6-kinase, independently of glucose transport (Fingar et al., 1993
). In addition, PI 3-kinase mediates the activation of the serine
kinase, protein kinase B, (Akt/PKB), that has also been
implicated in the regulation of glucose transport in adipocytes, thus, denoting an important role for PI 3-kinase as
an intermediate in this process (Kohn et al., 1996
). We
have obtained several independent experimental observations in the present studies to suggest that neither IRS-1
nor PI 3-kinase are directly associated with GLUT4-containing membranes, nor any membrane in the adipocyte
HSP fraction. First, IRS-1 and PI 3-kinase are insoluble in
nonionic detergents, whereas membrane proteins such as
GLUT4 are completely soluble under these conditions
(Fig. 6). Second, flotation analysis using sucrose density
gradient sedimentation of the HSP resolved this fraction
into two discrete peaks: one containing membranes, including GLUT4 vesicles, and the other containing nonmembrane-associated proteins. IRS-1 and PI 3-kinase
were exclusively found in the latter fraction and did not
overlap with the peak of GLUT4 (Fig. 7). Third, using velocity sedimentation, the majority of PI 3-kinase and IRS-1 were segregated from vesicles containing GLUT4 and
other proteins (Fig. 9). Finally, we were unable to detect
the presence of vesicular structures in gradient fractions
enriched in IRS-1 and PI 3-kinase (Fig. 12). Conversely,
these fractions were enriched in cytoskeletal elements,
which, based on their diameter (>10 nm), resembled cytoskeletal filaments. Thus, the present studies do not support the concept that insulin stimulates the recruitment of
PI 3-kinase to the intracellular GLUT4 compartment as
described previously (Heller-Harrison et al., 1996
). In this
report, it was suggested that this association may be very
transient, occurring at early times after insulin addition.
However, we have isolated the HSP from adipocytes incubated as described in the forementioned study, and subjected this fraction to gradient analysis as described above
(Fig. 7), and yet find no evidence for a direct association
between these signaling proteins and GLUT4 (data not
shown). It is also unlikely that these proteins dissociated
from membranes during the course of our isolation procedure because we were able to resediment both IRS-1 and
PI 3-kinase subsequent to flotation analysis (Fig. 8).
We have not clearly established, from the present studies, the molecular basis by which IRS-1 and PI 3-kinase are
targeted to what appears to be an insoluble protein matrix.
However, several observations support their interaction
with the cytoskeleton. First, the sucrose gradient fractions
which contain these proteins are highly enriched in cytoskeletal elements as determined by electron microscopy
(Fig. 12). Second, the cytoskeleton is reportedly insoluble
in nonionic detergents, readily sediments using ultra-centrifugation, and can be disrupted by high ionic strength
(Kries and Vale, 1993). IRS-1 and PI 3-kinase exhibited
each of these properties (Figs. 4-6). Third, the cytoskeleton would remain intact subsequent to permeabilization of
cells with SLO, and this is consistent with the maintenance
of a pool of IRS-1 and PI 3-kinase within SLO-permeabilized CHO/IR/IRS-1 cells (Fig. 11). Finally, it has been
shown that PI 3-kinase is highly enriched in cytoskeletal
fractions isolated from other cell types including platelets
(Zhang et al., 1992) and fibroblasts (Kapeller et al., 1993
).
We have attempted to immunolocalize both IRS-1 and PI
3-kinase in adipocytes and CHO/IR/IRS-1 cells. However,
these analyzes have been largely confounded by the lack
of specificity of available antibodies. Whereas IRS-1 appears to be localized to the cytosol in CHO cells (Sun et al., 1992
), this may reflect staining of the rather large cytosolic pool of IRS-1 that is evident in these cells (Fig. 11). We
have failed to observe an effect of agents known to disrupt
either microtubules or microfilaments on the distribution
of IRS-1 or PI 3-kinase in 3T3-L1 adipocytes (data not
shown). Furthermore, we do not observe any effect of
these agents on insulin action. Hence, the nature of this
putative cytoskeletal attachment remains to be determined.
If IRS-1 and PI 3-kinase are associated with the cytoskeleton in adipocytes, how then do they gain access to
their regulatory intermediates which, in this case, correspond to the insulin receptor and the inner leaflet of a lipid
bilayer, respectively? As described earlier, a large proportion of the available IRS-1 pool is rapidly phosphorylated
subsequent to insulin addition (Madoff et al., 1988) and
this occurs under conditions where internalization of the
insulin receptor is inhibited (Heller-Harrison et al., 1995
). One model that would account for these findings, is that
IRS-1 and PI 3-kinase may be tethered to elements of the
cytoskeleton that directly underlie the plasma membrane
of the cell. This structure, which is composed primarily of
actin filaments, has been documented in other cell types
and has been referred to as a membrane skeleton (Mays et
al., 1994
). This membrane skeleton may serve several important functions in adipocytes. First, by preassembling
the proteins that comprise the insulin-signaling cascade
onto a cytoskeletal scaffold, this may ensure the correct
juxtaposition of different enzymes in this cascade enabling
them to interact in a very robust manner. In this regard, it
is noteworthy that both IRS-1 and PI 3-kinase are found in
the cytoskeletal fraction in both nonstimulated adipocytes
and CHO/IR/IRS-1 cells (Figs. 9 and 10). Indeed, it will be
of interest to determine if other downstream signaling proteins are found at this location as well. Second, the cytoskeleton may provide a barrier through which recycling
vesicles have to transit en route to the cell surface. Several
studies have ascertained that receptor-mediated endocytosis and the trafficking of intracellular secretory vesicles to
the cell surface, in a variety of cell types, requires an intact
cytoskeleton (Mays et al., 1994
). Thus, by regulating the
integrity of this barrier, it may be possible to regulate the
recycling rate of certain membranes. In this respect, the PI
3-kinase inhibitor, wortmannin, has been shown to inhibit the insulin-regulated exocytosis of a number of membrane-associated proteins to the cell surface in adipocytes,
including the transferrin receptor and Rab4, in addition to
GLUT4 (Shepherd et al., 1995
; Cormont et al., 1996
). Finally, by regulating the association of integral signaling
molecules with this cytoskeletal scaffold, it may be possible to regulate hormonal responsiveness. Of note in this
regard, and consistent with recent studies (Heller-Harrison et al., 1995
), is the insulin-dependent release of IRS-1
from the HSP (Figs. 6, 7, and 9). It appears, from these
studies, that tyrosyl-phosphorylated IRS-1 is tightly retained
within the HSP, thus providing further evidence that the
insulin-dependent release of IRS-1 from this fraction may
correspond to serine phosphorylation of IRS-1. Temporal
differences in the phosphorylation of IRS-1 on tyrosine
versus serine residues in response to insulin have been reported, with serine phosphorylated IRS-1 predominating under prolonged insulin-stimulated conditions (Sun et al.,
1992
). In fact, serine phosphorylation of IRS-1 correlates
with reduced insulin signaling, as evident in cells treated
with okadaic acid (Tanti et al., 1994
) or tumor necrosis factor-
(Hotamisligil et al., 1996
). Hence, the release of IRS-1
from its cytoskeletal anchor, an event that may be triggered
by serine phosphorylation, may rapidly terminate the insulin signal simply by preventing access of IRS-1 to the IR.
In conclusion, these studies point to an important role
for the subcellular localization of signaling intermediates
in regulating specific biological events. Our data raise the
intriguing possibility that IRS-1 and one of its downstream
effectors, PI 3-kinase, are localized to the cytoskeleton. It
is within this context that both of these proteins are activated by the IR, suggesting that this scaffold must directly
appose the plasma membrane. This raises the question,
which represents the major impetus for these studies, as to
why the PDGF receptor, which is also enriched in the plasma membrane of adipocytes (Fig. 4 B) and binds PI 3-kinase
in response to PDGF stimulation (Fig. 3), is incapable of
regulating glucose transport (Fig. 1). One possibility is that
the attachment of PI 3-kinase to the cytoskeleton affords
access not only to the lipid bilayer, but also to the relevant
downstream target(s) of the 3'-phosphorylated phosphoinositide products of this enzyme, that may also be localized to this site. The other possibility is that the PDGF receptor may be sequestered within a microdomain of the
plasma membrane that prevents its access to these downstream targets and/or to the relevant lipid substrates which
result in the generation of 3'-phosphorylated phosphoinositides. In support of the latter, it has been shown that,
despite the recruitment of a significant amount of PI 3-kinase
to the plasma membrane in PDGF-treated adipocytes
(Fig. 3), PDGF does not significantly stimulate the production of 3' phosphorylated phospholipids (Conricode, 1995), nor does it activate downstream targets such as Akt/
PKB, with the same potency as insulin (Tanti et al., 1997
).
Such sequestration mechanisms may be important in terminally differentiated cells to subvert the inappropriate
activation of growth factor receptors.
![]() |
Footnotes |
---|
Received for publication 25 September 1997 and in revised form 29 December 1997.
Address all correspondence to David E. James, Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072, Australia. Tel.: (617) 3365 4986. Fax: (617) 3365 4430. E-mail: D.James{at}cmcb.uq.edu.auWe thank Teresa Boncker for excellent technical assistance in tissue culture. Thanks also to Shane Rea for support throughout this work. We are grateful to Dr. Gus Lienhard, Dr. Brian Druker, Dr. Mike Waters (University of Queensland, Brisbane, Australia), Dr. David Bowtel, and Dr. Margaret Robinson, for their generous donation of antibodies, and to Dr. Morris White for the gift CHO/IR/IRS-1 cells.
This work was supported by the National Health and Medical Research Council of Australia. The Centre for Molecular and Cellular Biology is a Special Research Centre of the Australian Research Council. D.E. James is a Wellcome Trust Professorial Research Fellow.
![]() |
Abbreviations used in this paper |
---|
anti-pY, anti-phosphotyrosine;
-OG,
-octylglucoside;
CYT, cytosol;
HDM, high density microsomes;
HSP, high speed pellet;
IC, intracellular;
IR, insulin receptor;
IRS-1, insulin receptor substrate-1;
MAPK, mitogen-activated protein kinase;
M/N, mitochondria/nuclei;
PI, phosphatidylinositide;
PIP, phosphatidylinositol 3'-phosphate;
PM, plasma membrane;
SLO, Streptolysin-O;
Tx-100, Triton
X-100.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Baltensperger, K., L.M. Kozma, A.D. Cherniack, J.K. Klarlund, A. Chawla, U. Banerjee, and M.P. Czech. 1993. Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science. 260: 1950-1952 |
2. | Brown, D.A., and J.K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68: 533-544 |
3. |
Cambier, J.C., and
K.S. Campbell.
1992.
Membrane immunoglobulin and its accomplices: new lessons from an old receptor.
FASEB (Fed. Am. Soc. Exp. Biol.) J.
6:
3207-3217
|
4. | Conricode, K.M.. 1995. Involvement of phosphatidylinositol 3-kinase in stimulation of glucose transport by growth factors in 3T3-L1 adipocytes. Biochem. Mol. Biol. Int. 36: 835-843 |
5. | Cormont, M., E. Van Obbergen, M. Zerial, and Y. Le Marchand-Brustel. 1996. Insulin induces a change in rab5 subcellular localization in adipocytes independently of phosphatidylinositol 3-kinase activation. Endocrinology. 137: 3408-3415 [Abstract]. |
6. |
Fingar, D.C.,
S.F. Hausdorff,
J. Blenis, and
M.J. Birnbaum.
1993.
Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes.
J. Biol. Chem.
268:
3005-3008
|
7. |
Fra, A.M.,
E. Williamson,
K. Simons, and
R.G. Parton.
1994.
Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae.
J.
Biol. Chem.
269:
30745-30748
|
8. |
Gold, M.R.,
V.W. Chan,
C.W. Turck, and
A.L. DeFranco.
1992.
Membrane Ig
cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes.
J.
Immunol.
148:
2012-2022
|
9. | Gonzalez, F.A., A. Seth, D.L. Raden, D.S. Bowman, F.S. Fay, and R.J. Davis. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J. Cell Biol. 122: 1089-1101 [Abstract]. |
10. | Gustafson, T.A., W. He, A. Craparo, C.D. Schaub, and T.J. O'Neill. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15: 2500-2508 [Abstract]. |
11. | Hara, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, and T.R. Jackson. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA. 91: 7415-7419 [Abstract]. |
12. |
Heller-Harrison, R.A.,
M. Morin, and
M.P. Czech.
1995.
Insulin regulation of
membrane-associated insulin receptor substrate 1.
J. Biol. Chem.
270:
24442-24450
|
13. |
Heller-Harrison, R.A.,
M. Morin,
A. Guilherme, and
M.P. Czech.
1996.
Insulin-mediated targeting of phosphatidylinositol 3-kinase to glut4-containing vesicles.
J. Biol. Chem.
271:
10200-10204
|
14. | Hiles, I.D., M. Otsu, S. Volinia, M.J. Fry, I. Gout, R. Dhand, G. Panayotou, L.F. Ruiz, A. Thompson, N.F. Totty, et al . 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 70: 419-429 |
15. |
Hotamisligil, G.S.,
P. Peraldi,
A. Budavari,
R. Ellis,
M.F. White, and
B.M. Spiegelman.
1996.
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-![]() |
16. |
Inukai, K.,
M. Funaki,
T. Ogihara,
H. Katagiri,
A. Kanda,
M. Anai,
Y. Fukushima,
T. Hosaka,
M. Suzuki,
B. Shin, et al
.
1997.
p85 alpha gene generates
three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI
3-kinase), p50![]() ![]() ![]() |
17. |
Izuhara, K., and
N. Harada.
1993.
Interleukin-4 (IL-4) induces protein tyrosine
phosphorylation of the IL-4 receptor and association of phosphatidylinositol
3-kinase to the IL-4 receptor in a mouse T cell line, HT2.
J. Biol. Chem.
268:
13097-13102
|
18. | James, D.E., and P.F. Pilch. 1988. Fractionation of endocytic vesicles and glucose-transporter containing vesicles in rat adipocytes. Biochem. J. 256: 725-732 |
19. | James, D.E., R. Brown, J. Navarro, and P.F. Pilch. 1988. Insulin-regulatable tissues express a unique insulin sensitive glucose transport protein. Nature. 333: 183-185 |
20. | James, D.E., M. Strube, and M. Mueckler. 1989. Molecular cloning and characterization of an insulin regulatable glucose transporter. Nature. 338: 83-87 |
21. | Kapeller, R., R. Chakrabarti, L. Cantley, F. Fay, and S. Corvera. 1993. Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3' kinase complexes - potential interactions with the microtubule cytoskeleton. Mol. Cell. Biol. 13: 6052-6063 [Abstract]. |
22. |
Katagiri, H.,
T. Asano,
H. Ishihara,
K. Inukai,
Y. Shibasaki,
M. Kikuchi,
Y. Yazaki, and
Y. Oka.
1996.
Overexpression of catalytic subunit p110-alpha of
phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes.
J. Biol. Chem.
271:
16987-16990
|
23. | Kazlauskas, A.. 1994. Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev. 4: 5-14 |
24. | Kazlauskas, A., A. Kashishian, J.A. Cooper, and M. Valius. 1992. GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit. Mol. Cell. Biol. 12: 2534-2544 [Abstract]. |
25. |
Kelly, K.L.,
N.B Ruderman, and
K.S. Chen.
1992.
Phosphatidylinositol-3-kinase in isolated rat adipocytes.
J. Biol. Chem.
267:
3423-3428
|
26. |
Kelly, K.L., and
N.B. Ruderman.
1993.
Insulin-stimulated phosphatidylinositol
3-kinase: association with a 185-kDa tyrosine-phosphorylated protein (IRS-1)
and localization in a low density membrane vesicle.
J. Biol. Chem.
268:
4391-4398
|
27. | Klippel, A., C. Reinhard, W.M. Kavanaugh, G. Apell, M.A. Escobedo, and L.T. Williams. 1996. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-tranducing kinase pathways. Mol. Cell. Biol. 16: 4117-4127 [Abstract]. |
28. |
Kohn, A.D.,
S.A. Summers,
M.J. Birnbaum, and
R.A. Roth.
1996.
Expression of a constitutively active akt ser/thr kinase in 3T3-L1 adipocytes stimulates
glucose uptake and glucose transporter 4 translocation.
J. Biol. Chem.
271:
31372-31378
|
29. | Kotani, K., A.J. Carozzi, H. Sakaue, K. Hara, L.J. Robinson, S.F. Clark, K. Yonezawa, D.E. James, and M. Kasuga. 1995. Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 209: 343-348 |
30. | Kries, T., and R. Vale, Editors. 1993. Guidebook to Cytoskeletal and Motor Proteins. Oxford University Press, Oxford, England. 276 pp. |
31. |
Kublaoui, B.,
J. Lee, and
P.F. Pilch.
1995.
Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes.
J. Biol. Chem.
270:
59-65
|
32. |
Kucera, G.L., and
S.E. Rittenhouse.
1990.
Human platelets form 3-phosphorylated phosphoinositides in response to alpha-thrombin, U46619 and GTP![]() |
33. | Kurchalia, T., P. Dupree, R.G. Parton, R. Kellner, H. Virta, M. Lehnert, and K. Simons. 1992. A 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118: 1003-1014 [Abstract]. |
34. |
Lavan, B.E.,
W.S. Lane, and
G.E. Lienhard.
1997.
The 60-kDa phosphotyrosine
protein in insulin-treated adipocytes is a new member of the insulin receptor
substrate family.
J. Biol. Chem.
272:
11439-11443
|
35. |
Lev, S.,
Y. Yarden, and
D. Givol.
1992.
Dimerization and activation of the kit
receptor by monovalent and bivalent binding of the stem cell factor.
J. Biol.
Chem.
267:
15970-15977
|
36. | Madoff, D.H., T.M. Martensen, and M.D. Lane. 1988. Insulin and insulin-like growth factor 1 stimulate the phosphorylation on tyrosine of a 160 kDa cytosolic protein in 3T3-L1 adipocytes. Biochem. J. 252: 7-15 |
37. | Marshall, C.J.. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4: 82-89 |
38. | Martin, S., J. Tellam, C. Livingstone, J.W. Slot, G.W. Gould, and D.E. James. 1996. The glucose transporter (GLUT-4) and vesicle-associated membrane protein-2 (VAMP-2) are segregated from recycling endosomes in insulin-sensitive cells. J. Cell Biol. 134: 625-636 [Abstract]. |
39. | Mays, R.W., K.A. Beck, and J.W. Nelson. 1994. Organization and function of the cytoskeleton in polarized epithelial cells: a component of the protein sorting machinery. Curr. Opin. Cell Biol. 6: 16-24 |
40. | Nave, B.T., R.J. Haigh, A.C. Hayward, K. Siddle, and P.R. Shepherd. 1996. Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem. J. 318: 55-60 |
41. |
Okada, T.,
L. Sakuma,
Y. Fukui,
O. Hazeki, and
M. Ui.
1994.
Blockage of
chemotactic peptide-induced stimulation of neutrophils by wortmannin as a
result of selective inhibition of phosphatidylinositol 3-kinase.
J. Biol. Chem.
269:
3563-3567
|
42. | Pearse, B.M.F.. 1982. Coated vesicles from human placenta carry ferritin, transferrin and immunoglobulin G. Proc. Natl. Acad. Sci. USA. 79: 451-455 [Abstract]. |
43. | Pelicci, G., L. Lanfrancone, R. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, F. Grignani, T. Pawson, and P.G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 70: 93-104 |
44. | Piper, R.C., L.J. Hess, and D.E. James. 1991. Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am. J. Physiol. 260: 570-580 . |
45. |
Posas, F., and
H. Saito.
1997.
Osmotic activation of the HOG/MAPK pathway
via STE11P MAPKKK - Scaffold role of PBS2P MAPKK.
Science.
276:
1702-1705
|
46. | Ricort, J.M., J.F. Tanti, E. Van Obberghen, and Y. Le Marchand-Brustel. 1996. Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes - a possible explanation for their specific effects on glucose transport. Eur. J. Biochem. 239: 17-22 [Abstract]. |
47. |
Robinson, L.J.,
S. Pang,
D.S. Harris,
J. Heuser, and
D.E. James.
1992.
Translocation of the glucose transporter (GLUT4) to the cell surface in permeablized 3T3-L1 adipocytes: effects of ATP, insulin, and GTP![]() |
48. |
Robinson, L.J.,
Z.F. Razzack,
J.C. Lawrence, and
D.E. James.
1993.
Mitogen-activated protein kinase activation is not sufficient for stimulation of glucose
transport or glycogen synthase in 3T3-L1 adipocytes.
J. Biol. Chem.
268:
26422-26427
|
49. | Shepherd, P.R., M.A. Soos, and K. Siddle. 1995. Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 211: 535-539 |
50. | Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387: 569-572 |
51. | Simpson, I.A., D.R. Yver, P.J. Hissin, L.J. Wardzala, E. Karnieli, L.B. Salans, and S.W. Cushman. 1983. Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions. Biochem. Biophys. Acta. 763: 393-407 |
52. | Skolnik, E.Y., A. Batzer, N. Li, C.H. Lee, E. Lowenstein, M. Mohammadi, B. Margolis, and J. Schlessinger. 1993. The function of Grb2 in linking the insulin receptor to Ras signaling pathways. Science. 260: 1953-1955 |
53. | Slot, J.W., H. J. Geuze, G. E. Lienhard, and D. E. James. 1991. Immunolocalization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J. Cell Biol. 113: 123-135 [Abstract]. |
54. | Stakoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science. 264: 1463-1467 |
55. | Sun, X.J., D.L. Crimmins, M.J. Myers, M. Miralpeix, and M.F. White. 1993. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13: 7418-7428 [Abstract]. |
56. |
Sun, X.J.,
M. Miralpeix,
M.J. Myers,
E.M. Glasheen,
J.M. Backer,
C.R. Kahn, and
M.F. White.
1992.
Expression and function of IRS-1 in insulin signal
transmission.
J. Biol. Chem.
267:
22662-22672
|
57. | Sun, X.J., P. Rothenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A. Wilden, D.A. Cahill, B.J. Goldstein, and M.F. White. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352: 73-77 |
58. |
Susa, M.,
M. Keeler, and
L. Varticovski.
1992.
Platelet-derived growth factor
activates membrane-associated phosphatidylinositol 3-kinase and mediates
its translocation from the cytosol. Detection of enzyme activity in detergent-solubilized cell extracts.
J. Biol. Chem.
267:
22951-22956
|
59. |
Tanti, J.F.,
T. Gremeaux,
E. Van Obberghen, and
Y. Le Marchand-Brustel.
1994.
Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.
J. Biol. Chem.
269:
6051-6057
|
60. |
Tanti, J.F.,
S. Grillo,
T. Gre'meaux,
P.J. Coffer,
E. Van Obberghen, and
Y. Le
Marchand-Brustel.
1997.
Potential role of protein kinase B in glucose
transproter 4 translocation in adipocytes.
Endocrinology.
138:
2005-2010
|
61. | Toker, A., and L.C. Cantley. 1997. Signaling through the lipid products of phosphatidylinositide 3-OH kinase. Nature. 387: 673-676 |
62. | Traverse, S., P. Cohen, H. Paterson, C. Marshall, U. Rapp, and R.J. Grand. 1993. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of Ras-transformed retinal cells. Oncogene. 8: 3175-3181 |
63. | Vandenberghe, N., D.M. Ouwens, J.A. Maassen, M.G.H. Vanmackelenbergh, H.C.M. Sips, and H.M.J. Krans. 1994. Activation of the ras-mitogen activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes. Mol. Biol. Cell. 14: 2372-2377 . |
64. | White, M.F.. 1994. The IRS-1 signaling system. Curr. Opin. Genet. Dev. 4: 47-54 |
65. |
Wiese, R.J.,
C.C. Mastick,
D.F. Lazar, and
A.R. Saltiel.
1995.
Activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes.
J. Biol. Chem.
270:
3442-3446
|
66. |
Yeh, T.C.,
W. Ogawa,
A.G. Danielsen, and
R.A. Roth.
1996.
Characterization and cloning of a 58/53-kda substrate of the insulin receptor tyrosine kinase.
J. Biol. Chem.
271:
2921-2928
|
67. |
Yenush, L.,
K.J. Makati,
J. Smithhall,
O. Ishibashi,
M.G. Myers, and
M.F. White.
1996.
The pleckstrin homology domain is the principle link between
insulin receptor and IRS-1.
J. Biol. Chem.
271:
24300-24306
|
68. |
Zhang, J.,
M.J. Fry,
M.D. Waterfield,
S. Jaken,
L. Liao,
J.E.B. Fox, and
S.E. Rittenhouse.
1992.
Activated phosphoinositide 3-kinase associates with
membrane skeleton in thrombin-exposed platelets.
J. Biol. Chem.
267:
4686-4692
|